Aim: Allelic polymorphism in codon 72 of the p53 tumor suppressor gene causes imbalance of p53 protein expression. Earlier studies have shown association between allelic polymorphism in codon 72 of the p53 gene with risk of ovary cancer (OC); however the results are inconclusive and conflicting. Therefore, we performed this meta-analysis to investigate the relation between p53 codon 72 Arg>Pro polymorphism and overall OC susceptibility.
Methods: We searched all eligible published studies based on the association between codon 72 of the p53 Arg>Pro polymorphism and risk of OC. Data were pooled together from individual studies and meta-analysis was performed. Pooled odds ratios (ORs) and 95% CI were calculated for allele contrast, homozygous, heterozygous, dominant and recessive genetic models.
Results: A total of twelve studies comprising of 993 OC cases and 1264 healthy controls were included in this meta-analysis. Overall, no significant association was detected for Pro allele carrier (Pro vs. Arg: p = 0.916; OR = 0.980, 95% CI = 0.677 to 1.419), homozygous (Pro/Pro vs. Arg/Arg: p = 0.419; OR = 0.731, 95% CI = 0.341 to 1.564), heterozygous (Arg/Pro vs. Arg/Arg: p = 0.248; OR = 1.237, 95% CI = 0.862 to 1.773), dominant (Pro/Pro+Arg/Pro vsArg/Arg: p = 0.699; OR = 1.089, 95% CI = 0.706 to 1.681), and recessive (Pro/Pro vs Arg/Arg+Arg/Pro: p = 0.329; OR = 0.754, 95% CI = 0.428 to 1.329) genetic models, respectively. Also, in the stratified analysis by ethnicity, no significant association of this polymorphism with risk of OC was found in the Caucasian population.
Conclusions: This meta-analysis suggested that codon 72 of the p53 Arg>Pro polymorphism may not significantly contribute in ovary cancer susceptibility. However, future large studies with gene-gene and gene-environment interactions are needed to validate these findings.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991634 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0094874 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Unveiling the etiological impact of GST-M1, GST-T1, and P53 genotypic variations on brain carcinogenesis.
Mol Biol Rep
December 2023
Department of Neurosurgery, Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Background: Functional variants of glutathione-S-transferase (GST)-M1, GST-T1, p53 might modulate brain cancer risk by altering the rate of metabolism and clearance of carcinogens from the brain tissue. In this study, the role of GST-M1, GST-T1, p53 polymorphisms on brain tumor was investigated.
Methods And Results: Brain tumor tissues of 143 patients were obtained from the Gulhane Training and Research Hospital, Department of Neurosurgery between 2019 and 2020.
Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia.
Front Oncol
October 2023
Laboratory of Molecular and Cellular Hematology, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Article Synopsis
- - Genetic variations in the gene can inactivate it, leading to a more aggressive form of chronic lymphocytic leukemia (CLL); specifically, the single nucleotide polymorphism (rs1042522:G>C) at codon 72 affects the protein's apoptotic potential.
- - A study in Tunisia involving 160 CLL patients and 160 matched healthy individuals found that the proline (Pro) variant of the gene is associated with a higher susceptibility to CLL and worse disease outcomes compared to the arginine (Arg) variant.
- - The Pro variant correlates with more severe CLL conditions, such as advanced Binet stage C, low hemoglobin levels, and low platelet counts, suggesting it may increase both the
TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Asian Pac J Cancer Prev
May 2023
Department of Molecular Biology & Genetics, Krishna Institute of Medical Sciences, "Deemed to be University", Taluka-Karad, Dist- Satara, Pin-415 539, (Maharashtra), India.
Article Synopsis
- - A case-control study in rural Maharashtra examined the connection between certain genetic variations (polymorphisms) in tumor suppressor genes p21 and p53 and breast cancer risk among women, involving 800 participants (400 breast cancer patients and 400 healthy controls).
- - The study specifically focused on four single nucleotide polymorphisms (SNPs) in the p21 and p53 genes and utilized PCR-RFLP methods to analyze blood samples, assessing the genetic risk factors using odds ratios and logistic regression.
- - Results showed that specific polymorphisms in the p21 gene, particularly the rs1801270 SNP, were negatively associated with breast cancer risk, indicating that certain genetic variations may offer some level of protection in
Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.
Asian Pac J Cancer Prev
January 2023
Molecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.
Background: The polymorphisms Arg72Pro in the TP53 gene (rs1042522) and Ile655Val in the HER2 gene (rs1136201) have been related to susceptibility to several types of cancer. Different studies show the association of these polymorphisms with breast cancer, so our aim in this study was to investigate whether the Arg72Pro and Ile655Val polymorphisms have any influence on the risk of developing breast cancer in women from the city of Macapá, Amapá, located in the brazilian amazon region.
Methods And Results: We then analyzed 80 DNA samples from women with breast cancer and 83 DNA samples from women without the disease, by the Restriction Fragment Length Polymorphism - Polymerase Chain Reaction (PCR-RFLP) technique.
TP53 Codon 72 Polymorphism and the Risk of Colorectal Cancer in an Azerbaijani Population.
Turk J Gastroenterol
June 2022
Department of General Surgery, Scientific Center of Surgery, Baku, Azerbaijan.
Background: We aimed to evaluate the association between the TP53 Arg72Pro gene polymorphism and risk of colorectal cancer in an Azerbaijani population.
Methods: A total of 141 patients with colorectal cancer and 150 gender- and age-matched controls were involved in the study. The genotypes of the TP53 gene Arg72Pro polymorphism were detected by polymerase chain reaction-based restriction fragment length polymorphism analysis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!